JPS525764A - Production of pyrrolidone - Google Patents
Production of pyrrolidoneInfo
- Publication number
- JPS525764A JPS525764A JP51075954A JP7595476A JPS525764A JP S525764 A JPS525764 A JP S525764A JP 51075954 A JP51075954 A JP 51075954A JP 7595476 A JP7595476 A JP 7595476A JP S525764 A JPS525764 A JP S525764A
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolidone
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752528664 DE2528664A1 (de) | 1975-06-27 | 1975-06-27 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS525764A true JPS525764A (en) | 1977-01-17 |
Family
ID=5950059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51075954A Pending JPS525764A (en) | 1975-06-27 | 1976-06-26 | Production of pyrrolidone |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS525764A (sv) |
| AT (1) | AT365575B (sv) |
| BE (1) | BE843505A (sv) |
| CH (1) | CH623809A5 (sv) |
| DE (1) | DE2528664A1 (sv) |
| DK (1) | DK287476A (sv) |
| ES (1) | ES449095A1 (sv) |
| FR (1) | FR2316943A1 (sv) |
| GB (1) | GB1553595A (sv) |
| IL (1) | IL49916A0 (sv) |
| LU (1) | LU75235A1 (sv) |
| NL (1) | NL7606773A (sv) |
| SE (1) | SE7607331L (sv) |
| ZA (1) | ZA763802B (sv) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| JP2011116768A (ja) * | 2002-05-14 | 2011-06-16 | Allergan Inc | 眼圧降下剤としての８−アザプロスタグランジン類似体 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE423813B (sv) * | 1976-08-06 | 1982-06-07 | Pfizer | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper |
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
| GEP20043203B (en) | 1999-12-22 | 2004-03-25 | Pfizer Prod Inc | EP4 Receptor Selective Agonists in the Treatment of Osteoporosis |
| OA12533A (en) | 2000-11-27 | 2006-06-05 | Pfizer Prod Inc | Ep4 receptor selective agonists in the treatment of osteoporosis. |
| CA2451392A1 (en) | 2001-07-16 | 2003-01-30 | F. Hoffmann-La Roche Ag | Prostaglandin analogues as ep4 receptor agonists |
| CN100371322C (zh) | 2001-07-16 | 2008-02-27 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素类化合物激动剂的2-吡咯烷酮衍生物 |
| EP2255829A3 (en) | 2001-07-23 | 2012-03-28 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient |
| WO2003077910A1 (en) * | 2002-03-18 | 2003-09-25 | Pfizer Products Inc. | Methods of treatment with selective ep4 receptor agonists |
| CA2511255C (en) | 2003-01-10 | 2009-04-07 | F. Hoffmann-La Roche Ag | 2-piperidone derivatives as prostaglandin agonists |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| WO2014015247A1 (en) | 2012-07-19 | 2014-01-23 | Cayman Chemical Company, Inc. | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions |
| US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
| CA2903314C (en) | 2013-03-15 | 2023-02-14 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
| PT2989098T (pt) | 2013-03-15 | 2017-08-16 | Cayman Chemical Co Inc | Compostos de lactama como agonistas selectivos do receptor ep4 para uso no tratamento de doenças e condições mediadas por ep4 |
| KR20160048054A (ko) | 2013-07-19 | 2016-05-03 | 카이맨 케미칼 컴파니 인코포레이티드 | 골 성장의 촉진을 위한 방법, 시스템 및 조성물 |
-
1975
- 1975-06-27 DE DE19752528664 patent/DE2528664A1/de not_active Withdrawn
-
1976
- 1976-06-22 ES ES449095A patent/ES449095A1/es not_active Expired
- 1976-06-22 NL NL7606773A patent/NL7606773A/xx not_active Application Discontinuation
- 1976-06-24 SE SE7607331A patent/SE7607331L/sv unknown
- 1976-06-24 CH CH809976A patent/CH623809A5/de not_active IP Right Cessation
- 1976-06-24 LU LU75235A patent/LU75235A1/xx unknown
- 1976-06-25 GB GB26564/76A patent/GB1553595A/en not_active Expired
- 1976-06-25 IL IL49916A patent/IL49916A0/xx unknown
- 1976-06-25 DK DK287476A patent/DK287476A/da unknown
- 1976-06-25 ZA ZA763802A patent/ZA763802B/xx unknown
- 1976-06-25 AT AT0467976A patent/AT365575B/de active
- 1976-06-26 JP JP51075954A patent/JPS525764A/ja active Pending
- 1976-06-28 FR FR7619563A patent/FR2316943A1/fr active Granted
- 1976-06-28 BE BE168390A patent/BE843505A/xx not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| JP2011116768A (ja) * | 2002-05-14 | 2011-06-16 | Allergan Inc | 眼圧降下剤としての８−アザプロスタグランジン類似体 |
Also Published As
| Publication number | Publication date |
|---|---|
| LU75235A1 (sv) | 1977-03-16 |
| DE2528664A1 (de) | 1977-01-13 |
| GB1553595A (en) | 1979-09-26 |
| AT365575B (de) | 1982-01-25 |
| FR2316943B1 (sv) | 1978-11-03 |
| FR2316943A1 (fr) | 1977-02-04 |
| BE843505A (fr) | 1976-12-28 |
| ES449095A1 (es) | 1977-12-16 |
| ZA763802B (en) | 1977-05-25 |
| ATA467976A (de) | 1981-06-15 |
| NL7606773A (nl) | 1976-12-29 |
| DK287476A (da) | 1976-12-28 |
| IL49916A0 (en) | 1976-08-31 |
| CH623809A5 (en) | 1981-06-30 |
| SE7607331L (sv) | 1976-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS51118763A (en) | Production of alkylenecarbonate | |
| JPS5236683A (en) | Production of riphamycin | |
| JPS525764A (en) | Production of pyrrolidone | |
| JPS5212162A (en) | Production of phenylindoline | |
| JPS51141897A (en) | Production of riphamycin | |
| JPS5251392A (en) | Production of triazolopyridazinones | |
| JPS51131873A (en) | Production of 44loneralkyll 55cyanoooxazole | |
| JPS527958A (en) | Production of 22 pyrrolidone | |
| JPS5248698A (en) | Production of riphamycin | |
| JPS525762A (en) | Production of betaa acylpyrol | |
| JPS5273865A (en) | Production of novel pyrrolidone | |
| JPS51115473A (en) | Production of lower alkylimidazolecarboxylate | |
| JPS5289667A (en) | Production of nnsubstituted spirolaltam | |
| JPS5219695A (en) | Production of tetrahydrothiopyranopyrazols | |
| JPS5248689A (en) | Production of pyrazolopyridineketones | |
| JPS51115465A (en) | Production of 55phenyll 22framidoxime | |
| JPS5227758A (en) | Production of 22methyll 11naphthol | |
| JPS51130543A (en) | Production of instant onigiri | |
| JPS5273858A (en) | Production of phospholenee 11calcogenite | |
| JPS5248662A (en) | Production of 44hydroxymethyll 22pyrorysines | |
| JPS5236690A (en) | Production of 33methoxymethlcephalosporin | |
| JPS5212991A (en) | Production of bioprotein | |
| JPS5246100A (en) | Production of pyrazolopyridopirimidine | |
| JPS51128997A (en) | Production of pyrazolopyridineketones | |
| JPS5277057A (en) | Production of nnalkenyll22 aminomethylpyrolidines* |